SciaticaPhase 4NCT02777320
Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department
A Phase 4 study testing paracetamol and Ibuprofen in people with Sciatica, run by Pamukkale University at 1 site in Turkey (Türkiye).
Trial summary
Currently, Paracetamol and Ibuprofen are widely used by emergency physicians in Turkey for the pain treatments. The objective of the study was to assess whether intravenous Paracetamol has superior Sciatica pain reduction will compare with Ibuprofen in emergency department (ED) adults. Read more about this study
- Who is it for?
- Ages 21 to 65 years
- Conditions the study is for
- Sciatica
- What is being tested?
- paracetamol and Ibuprofen
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Mar 2016to Sep 2016
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients who presented with complaints of leg pain radiating the sciatic nerve tracings to the emergency services (Which may or may not be accompanied back pain),
- Positive Laseque test identified patients in physical examination,
- Patients whose complaints have started in the last week,
- Younger than 21 years old,
- Older than 65 years old.
Who cannot join
- Patients who have a leg or low back pain longer than a week Have a direct blunt trauma to the legs or lumbar area in the last week,
- Pretreatment linear 100-mm visual analog scale (VAS) pain score less than 40 mm,
- Patients who have drop foot, paralysis and other neurological symptoms in physical examination.
- Patients with blood pressure less than 90mmHg in the arrival of emergency services.
- Patients with malignancy, cauda equina syndrome, ankylosing spondylitis, rheumatoid arthritis or inflammatory arthritis contain any of the disease in his/her CV.
- Patients with any history of chronic pain syndrome.
Show all 13Show fewer
- Patients who receive pain killers, antidepressants, anticonvulsants, muscle relaxants, steroids within 6 hours before the ED visit,
- Patients with a history of Substance Dependence or alcohol abuse
- Patients had a fever (>37.9)
- Allergy or previous adverse reaction to the studied drugs(Ibuprofen, Paracetamol), received agents to inhibit the secretion of acid (PPIs or histamine-2 receptor antagonists), antispasmodics, or nonsteroidal anti-inflammatory drugs
- were pregnant or breast-feeding,
- inability to comprehend the VAS evaluation,
- or refused to participate in the study
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Pamukkale University
Denizli, 20070
Mustafa SERINKEN, Professor, +905052991497, aserinken@hotmail.com
Hayri ELİÇABUK, MD, +905385079500, hayrielicabuk@hotmail.com
About this study
Official title: Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial.
Currently, Paracetamol and Ibuprofen are widely used by emergency physicians in Turkey for the pain treatments.
The objective of the study was to assess whether intravenous Paracetamol has superior Sciatica pain reduction will compare with Ibuprofen in emergency department (ED) adults.
Half of the participants will receive Paracetamol and the other half will receive Ibuprofen.
Read the detailed description
Paracetamol and Ibuprofen each relieve pain witf different mechanisms.
Paracetamol is termed a simple analgesic and an antipyretic. Despite enduring assertions that it acts by inhibition of cyclooxygenase (COX)-mediated production of prostaglandins, unlike non-steroidal anti-inflammatory drugs (NSAIDs).
Ibuprofen is the most commonly used and most frequently prescribed NSAID. It is a non-selective inhibitor of cyclo-oxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).4 Although its anti inflammatory properties may be weaker than those of some other NSAIDs, it has a prominent analgesic and antipyretic role.
In our trial; The investigators aimed to compare intravenous Paracetamol and Ibuprofen in patient with Sciatica
- All patients eligible for the study(Approximately 200 patient with sciatica) were randomized to one of two groups:
- First Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes.
- 100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume.
- Second Group: 400 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes.
- Drug packs were prepared according to the computer-generated random number sequence to assign treatment allocations
- The allocation list was kept by the emergency nurse. Patients received the paracetamol or Ibuprofen medication schemes according to their random allocations.
- After enrollment and recording of baseline information, the next numbered study drug pack was obtained, and administered as a infusion over 5 minutes.
- Randomization was achieved by using computer software to generate random numbers.
- One researcher blinded to patient allocation observed the whole procedure and recorded the Sciatica pain scores.
- Patients in both groups received two types of medication in a similar manner (for example, 150 ml normal saline given as a slow intravenous infusion over 5 minutes), thus ensuring double blinding.
- Sciatica pain scores were recorded at 0, 15, and 30 min on a VAS of 1 to 10
- Rescue medication is given patients If the clinician think it's necessary within 30 minutes after study drug administration.
- All other medications required during the study also were recorded.
- Conditions
- Sciatica
- Being tested
- paracetamol, Ibuprofen
- Keywords
- Sciatica, Ibuprofen, Paracetamol, Emergency Medicine
- Medical subject headings
- Sciatica
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
paracetamolDrug
Also called Perfalgan, Partemol, Parol
1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes (100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume)
IbuprofenDrug
Also called Intrafen, Caldolon
400 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes
| Study group | Role | What they receive |
|---|---|---|
| paracetamol group | Experimental | First Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes. (100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume) Receives: Drug: paracetamol |
| Ibuprofen group | Experimental | Second Group: 400 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes Receives: Drug: Ibuprofen |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction of Sciatica pain in Visual Analog Scale İn 30 minutes.
this work tooks 6 mounts
Measured: Sciatica pain scores will be recorded at 0, 15, and 30 min.
Secondary outcomes (1)
Adverse events
30 minutes after the study drug administered
Measured: 30 minutes after the drug administered.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 May 2016 (estimated)
- Study startMar 2016
- Primary completionAug 2016 (estimated)
- Study completionSep 2016 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SciaticaStudies of the same condition, open and under way.
- More trials run by Pamukkale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Investigator
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Pamukkale University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mustafa Serinken, Pamukkale University
- Investigators
- Mustafa SERINKEN, professor, Study director, Pamukkale UniversityCenker EKEN, associate professor, Study director, Akdeniz University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02777320
- Sponsor's protocol ID
- Sciatica-IvsP
- Status last verified
- Jul 2016
- First submitted
- 17 May 2016
- Last updated
- 15 Jul 2016
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 15 Jul 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Intravenous Ibuprofen and Paracetamol in Patients With Sciatica Presented to the Emergency Department: A Randomized, Double-Blind, Controlled Trial.
- ClinicalTrials.gov ID
- NCT02777320
- Acronym / sponsor ID
- Sciatica-IvsP
- Conditions
- Sciatica
- Keywords
- Sciatica, Ibuprofen, Paracetamol, Emergency Medicine
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Pamukkale UniversityUniversity, hospital or other
- Study start
- Mar 2016
- Primary completion
- Aug 2016 (estimated)
- Study completion
- Sep 2016 (estimated)
- First posted
- 19 May 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Currently, Paracetamol and Ibuprofen are widely used by emergency physicians in Turkey for the pain treatments.
The objective of the study was to assess whether intravenous Paracetamol has superior Sciatica pain reduction will compare with Ibuprofen in emergency department (ED) adults.
Half of the participants will receive Paracetamol and the other half will receive Ibuprofen.
Detailed description
Paracetamol and Ibuprofen each relieve pain witf different mechanisms.
Paracetamol is termed a simple analgesic and an antipyretic. Despite enduring assertions that it acts by inhibition of cyclooxygenase (COX)-mediated production of prostaglandins, unlike non-steroidal anti-inflammatory drugs (NSAIDs).
Ibuprofen is the most commonly used and most frequently prescribed NSAID. It is a non-selective inhibitor of cyclo-oxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).4 Although its anti inflammatory properties may be weaker than those of some other NSAIDs, it has a prominent analgesic and antipyretic role.
In our trial; The investigators aimed to compare intravenous Paracetamol and Ibuprofen in patient with Sciatica
- All patients eligible for the study(Approximately 200 patient with sciatica) were randomized to one of two groups:
- First Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes.
- 100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume.
- Second Group: 400 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes.
- Drug packs were prepared according to the computer-generated random number sequence to assign treatment allocations
- The allocation list was kept by the emergency nurse. Patients received the paracetamol or Ibuprofen medication schemes according to their random allocations.
- After enrollment and recording of baseline information, the next numbered study drug pack was obtained, and administered as a infusion over 5 minutes.
- Randomization was achieved by using computer software to generate random numbers.
- One researcher blinded to patient allocation observed the whole procedure and recorded the Sciatica pain scores.
- Patients in both groups received two types of medication in a similar manner (for example, 150 ml normal saline given as a slow intravenous infusion over 5 minutes), thus ensuring double blinding.
- Sciatica pain scores were recorded at 0, 15, and 30 min on a VAS of 1 to 10
- Rescue medication is given patients If the clinician think it's necessary within 30 minutes after study drug administration.
- All other medications required during the study also were recorded.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Triple blind (participant, care provider, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| paracetamol group | Experimental | Drug: paracetamolFirst Group: 1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes. (100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume) |
| Ibuprofen group | Experimental | Drug: IbuprofenSecond Group: 400 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes |
Who may qualify
- Ages
- 21 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Patients who presented with complaints of leg pain radiating the sciatic nerve tracings to the emergency services (Which may or may not be accompanied back pain),
- Positive Laseque test identified patients in physical examination,
- Patients whose complaints have started in the last week,
- Younger than 21 years old,
- Older than 65 years old.
Key exclusion criteria (13 listed)
- Patients who have a leg or low back pain longer than a week Have a direct blunt trauma to the legs or lumbar area in the last week,
- Pretreatment linear 100-mm visual analog scale (VAS) pain score less than 40 mm,
- Patients who have drop foot, paralysis and other neurological symptoms in physical examination.
- Patients with blood pressure less than 90mmHg in the arrival of emergency services.
- Patients with malignancy, cauda equina syndrome, ankylosing spondylitis, rheumatoid arthritis or inflammatory arthritis contain any of the disease in his/her CV.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| paracetamolAlso: Perfalgan, Partemol, Parol1000 mg Paracetamol in 150 ml normal saline given as a slow intravenous infusion over 5 minutes (100 ml of saline is removed before the addition of the 100 ml paracetamol to be the same volume) | Drug | paracetamol group |
| IbuprofenAlso: Intrafen, Caldolon400 mg Ibuprofen in 150 ml normal saline given as a slow intravenous infusion over 5 minutes | Drug | Ibuprofen group |
Primary outcome
Reduction of Sciatica pain in Visual Analog Scale İn 30 minutes.
Time frame: Sciatica pain scores will be recorded at 0, 15, and 30 min.
this work tooks 6 mounts
1 secondary outcome
Adverse events
Time frame: 30 minutes after the drug administered.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Jul 2016.
- Individual participant dataSharing planned: Undecided
Related trials for Sciatica
Recruiting
Effect of Transfer of Energy Capacitive and Resistive on Chronic Discogenic Sciatica
Lumbar Radiculopathy
Not yet recruiting
Selective Nerve Root Block Versus Sham to Reduce Surgery for Lumbar Disc Herniation
Lumbar Disc Herniation, Lumbar Radiculopathy
RecruitingPhase 1
Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy
Lumbosacral Radicular Pain, Sciatic Radiculopathy
Recruiting
Effect of Sensorimotor Training on Pain and Gait Performance in Patients With Discogenic Sciatica
Sciatica Due to Intervertebral Disc Disorder
Not yet recruiting
Randomized Evaluation of Lumbar Injection Effectiveness and Function
Lumbar Radiculopathy, Lumbar Disc Herniation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mustafa SERINKEN, professor study director
Pamukkale University
Cenker EKEN, associate professor study director
Akdeniz University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing paracetamol and Ibuprofen in people with Sciatica, run by Pamukkale University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 15 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mustafa SERINKEN, professor (+905052991497, aserinken@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction of Sciatica pain in Visual Analog Scale İn 30 minutes. (time frame: Sciatica pain scores will be recorded at 0, 15, and 30 min.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2016; AzTrials last refreshed its copy on 8 Nov 2026.